We conducted a 9-month prospective cohort study of 2,527 patients with systemic inflammatory response syndrome in three intensive care units and three general wards in a tertiary health care institution. Markov models were developed to predict the probability of movement to and from more severe stages -sepsis, severe sepsis, or septic shock -at 1, 3, and 7 days. For patients with sepsis, severe sepsis, and septic shock, the probabilities of remaining in the same category after 1 day were .65, .68, and .61, respectively. The probability for progression after 1 day was .09 for sepsis to severe sepsis and .026 for severe sepsis to shock. The probability of patients with sepsis, severe sepsis, and septic shock dying after 1 day was .005, .009, and .079, respectively. The model can be used to predict the reduction in end organ dysfunction and mortality with use of increasingly effective antisepsis agents.
A uniform set of definitions for sepsis and related syndromes to 100,000 deaths per year [2] and is the most common cause of mortality in noncoronary intensive care units (ICUs) [3, 4] . was proposed in a consensus conference in 1991 [1] . For patients meeting criteria for the systemic inflammatory response syn-
The most recent data on vital statistics indicate that the entity septicemia represents the 13th leading cause of death in the drome (SIRS), the three terms proposed were sepsis, severe sepsis, and septic shock. SIRS was defined as two or more of United States, with an age-adjusted death rate of 7.9 per 100,000 population in 1993 [5] . the following: hypothermia or fever (temperature, õ36ЊC or ú38.5ЊC, respectively), tachycardia (ú90 beats/min), tachypnea
In a prospective, hospital population -based study of sepsis [6] , we found that the consensus conference definitions were (ú20 breaths/min), and leukocytosis (ú12,000 WBCs/mm 3 ), leukopenia (õ4,000 WBCs/mm 3 ), or an increase in the number consistent with the hypothesis of a hierarchical progression in patients from sepsis to severe sepsis and to septic shock. The of immature band forms (ú10%). Sepsis was defined as SIRS plus a documented infection. Severe sepsis was defined as sepsis evidence for the stages included the progressive increase in rates of endorgan dysfunction, proportion of patients with docuplus hypotension or peripheral manifestations of hypoperfusion abnormalities. Septic shock was defined as severe sepsis plus mented bloodstream infections, and mortality. We also observed that from 44% to 71% of patients in any category of hypotension refractory to a 500-mL fluid challenge [1] .
Sepsis, severe sepsis, and septic shock are not discrete disthe sepsis cascade had spent at least 1 day in the preceding state of the biological response syndrome before progression. ease identities but newly defined stages of the nonspecific systemic inflammatory response to major biological insults. Most Once a disease is reasonably stratified into distinct stages, it is possible to define the transition rates for progression or of the biological insults result from infection [2] . Estimates of the frequency of the syndrome of sepsis in the United States regression from one stage to the other [7] . Multistate models have been used to define the probabilities of advancing from range up to 500,000 cases a year [2] ; 40% (200,000) of these patients develop septic shock. Septic shock accounts for 80,000 one stage to another in patients with cancer, diabetic retinopathy, or HIV infection [8, 9] . Models have also been used in other ways (e.g., for defining the duration of stages of disease by using laboratory markers such as CD4 T lymphocyte counts) [10] . Herein, we report the transitional probabilities for each are admitted each year. During the study period (1 August 1992 to 30 April 1993), concurrent incidence surveys for the three putative stages of the syndrome of sepsis were performed on three ICUs and three wards. We surveyed 3,708 patients, of whom 2,527 met criteria for SIRS. The latter study cohort were followed up for a total of 30,126 days [6] .
Surveillance
Prospective surveillance during the 9-month study was performed in a medical ICU with 12 beds, a surgical ICU with weekday [6] . At the time of enrollment in the study, a special õ36ЊC or ú38.5ЊC, respectively), tachycardia (ú90 beats/min), tachypnea (ú20 breaths/min), and/or leukocytosis (ú12,000 WBCs/ case report form was completed, on which demographic and study if they had been discharged from the ICU after a stay of õ12 hours. All patients enrolled in the study were followed up for 28 days or until discharge from the hospital if it occurred top to bottom: these are the stages at the starting point of the before 28 days. Sepsis, severe sepsis, septic shock, and end analysis. The final stages, attained at defined intervals, are listed organ dysfunction were included as end points. A high level from left to right. Then either the number of people who have of interrater reliability was obtained among study nurses (k, moved from one stage to the next or the probability of moving 0.91; range, 0.6 -1.0), with a sensitivity of 85% and a specificfrom one stage to the next over a specific time frame can ity of 96% for recording data [6] .
be examined. In the model presented herein, we specifically examined transition for 1, 3, and 7 days.
Definitions of the Biological Response to Infection and End
We constructed a Markov matrix by referencing the starting
Organ Dysfunction
point and examining three stages of interest (sepsis, severe The definitions that we employed for SIRS, sepsis, severe sepsis, and septic shock) as well as the two absorbing states sepsis, and septic shock were adapted from those reported by (discharge and death). Progression both forward or backward the American College of Chest Physicians/Society of Critical from one stage to another as shown in figure 1 can be envisaged. Care Medicine Consensus Conference [1] . We also noted if For example, an individual might move from severe sepsis to patients met only two, three, or all four of the components septic shock or from septic shock back to severe sepsis. In the of SIRS [6] . Definitions of end organ dysfunction have been Markov process, an absorbing state is defined as a state from described previously [6, 12, 13] .
which no transition to other states can occur (e.g., death). Following Beck and Pauker [7] , transition rates from stage to stage were calculated from the observations by using the formula R ij
Statistical Analysis
Å N ij /N i , where N ij is equal to the number of transitions over two consecutive days from stage i to stage j and N i is equal to The Markov chains model is a probability model based on the development of a transition matrix that describes the likelithe total number of person transition days for stage i. Once again, following Beck and Pauker [7] , the transition probability hood of change from one stage to another. In developing the model, the specific stages, the time intervals of interest, and is calculated as P ij Å 1 0 exp(0RT), where R equals the transition rate and T is the time period (T Å 1, 3, or 7 days). the absorbing or final stages in the continuum are defined [7] . Markov models assume that a patient is always in one of a
In our calculations, we determined daily transition probabilities; the total number of patient-days was 30,126. These calcufinite number of discrete health states, called Markov states. The ability of the Markov model to represent repetitive events lations for a 1-, 3-, or 7-day time interval or any time interval of interest can also be performed. The Markov process is an and the time dependence of both probabilities and utilities allow for accurate representation of clinical settings [14] . A matrix example of a stochastic process that has a special property. The Markov property states that the probability that an individis defined with the sequential stages listed individually from NOTE. SIRS Å systemic inflammatory response syndrome. Matrix of probabilities for the five sequential stages (no SIRS, SIRS, sepsis, severe sepsis, and septic shock) and the two absorbing stages (discharge being alive and death) are presented. Numbers are probabilities after 1, 3, and 7 days. Stages at start are listed from top to bottom, and final stages attained at different intervals are listed from left to right. Probabilities refer specifically to the probability of moving from one stage to the next over the specified time frame. For example, in part A, .6816 (no SIRS, no SIRS) refers to the probability of staying in this stage (no SIRS) over a 1-day period; similarly, .0916 (sepsis, severe sepsis) in part A refers to the probability of advancing from sepsis to severe sepsis after 1 day. Probabilities have been rounded off in the text for further clarity. ual moves to a particular state at time i / 1 is dependent only After 3 days, between 40% and 55% of patients with sepsis, on the individual's state at time i and does not depend on any severe sepsis, or septic shock remained in the same stage (table history. In this context, this assumption means that knowledge 1, part B). It is noteworthy that from 6.9% to 31% of patients that an individual is in a particular state such as SIRS is the improved. Of those patients with sepsis, 8.7% developed severe only piece of information needed to calculate the probability sepsis; of those with severe sepsis, 2.5% developed septic of an individual's move to a different state (i.e., any history shock. After 7 days, between 23% and 45% of patients in any that led the individual to the SIRS state is immaterial). This of the three stages remained in the same stage (table 1, part assumption may be difficult to justify in many medical settings C). Of those patients with sepsis and severe sepsis, 8.1% and but may be appropriate for studies involving relatively short 2.8%, respectively, progressed to a more severe stage, whereas follow-up times.
of those with sepsis, severe sepsis, and septic shock, 12%, 14%, and 27%, respectively, regressed to a less severe stage. The mortality rate was higher as more criteria of SIRS were Results met. The highest mortality rate was among patients with septic shock after 1 day (7.9%), decreasing after 3 days (4.0%) and During the 9-month period, 2,527 (68%) of the 3,708 patients 7 days (3.5%) (figure 2). We also calculated the probability of admitted to the surveyed wards met the criteria for SIRS. The developing severe sepsis, septic shock, or death after meeting more criteria for SIRS with which the patients presented, the criteria for sepsis, independently of the day that it happened; higher the probability for having evidence of infection and thus the probabilities were .72, .17, and .16, respectively. Similarly, meeting criteria for sepsis after 1 day (RR: 1.0, 1.37 [95% CI, the overall proportions of individuals who developed end organ 0.87 -2.17], and 2.03 [95% CI, 1.20 -3.46]) for two, three, and dysfunction were as follows: adult respiratory distress synfour criteria, respectively (x 2 for linear trends, 6.94; P Å .008). drome, 4.6%; acute renal failure, 13.9%; and disseminated inBy 1 day, between 61% and 68% of patients in any stage travascular coagulation, 13.9%. of the sepsis cascade (sepsis, severe sepsis, or septic shock)
The data can be used to predict what would be the effect of remained at the same level, and between 3.1% and 21% rean antisepsis agent that was increasingly effective in decreasing gressed to a less severe stage (table 1, part A). Nine percent the probability of moving to a more severe stage of the sepsis of those with sepsis progressed to severe sepsis, and 2.6% initially with severe sepsis had progressed to septic shock.
cascade. For example, with use of the transition rate, the effect / 9c51$$jy40 06-16-98 00:20:06 cida UC: CID veloping a more severe stage of the biological response or in estimating the change in probability with effective therapy. As previously reported [6] , a progressively higher mortality rate was observed as more severe inflammatory response criteria were met. The 28-day mortality rates among patients with sepsis, severe sepsis, and septic shock were 13%, 18%, and 46%, respectively. In the present analysis, for patients with septic shock, the probability of death after 1 day was .079 and decreased 51% after 3 days and 44% after 7 days, thus indicating that the highest probability of dying was in the first 3 days. Sixty-five percent of the patients with sepsis remained in the sepsis stage after 1 day, but only 55% and 45% remained in the sepsis stage after 3 and 7 days, respectively. Moreover, the probability of progressing to severe sepsis was .092, .087, and Figure 2 . Probability of mortality due to systemic inflammatory .081 after 1, 3, and 7 days, respectively; the probability of response syndrome (SIRS), sepsis, severe sepsis, and septic shock improving was .031, .069, and .12 after 1, 3, and 7 days, after 1, 3, and 7 days according to the Markov model. The mortality rate associated with septic shock was higher after 1 day (7.9%),
respectively. It appears that as more days passed, the probabilcompared with those after 3 days (4%) and 7 days (3.5%).
ity of improving was higher. These data stress the importance of early intervention to prevent the progression to more advance stages or death in patients in the sepsis cascade, in particular in those with septic shock. of an antisepsis agent with a 50% effectiveness for preventing patients with sepsis from advancing to severe sepsis could be Transitional probabilities can also be used to compare the effectiveness of two or more treatments, when end points crudely estimated; the model predicts that the probability of death would fall from .16 to .08. Similarly, the probability of other than mortality are of interest. End points of interest could be the length of time (days in this case) within a deterdeveloping severe sepsis would decline from .72 to .36. mined stage or the probability of advancing to the next more severe stage of disease. This could be particularly important Discussion in therapies for sepsis that could decrease the probability of developing end organ dysfunction. Similarly, effective theraSome reasons for constructing multistate models are to provide a comprehensive view of a disease process, to allow an pies might reduce the duration (days) in a relatively severe stage of sepsis, and evolving organ dysfunction that develops estimation of the proportions of individuals who will be in the various stages at some time in the future, and to make more in the course of sepsis markedly influences the outcome of critically ill patients [13] . Interventions aimed at improving efficient use of incomplete information when only small proportions of individuals' disease histories are available [15] . the quality of care could be measured in the decreased number of days that patients are in a particular stage with defined end Such multistage models have been used to explain the natural history of diverse diseases. Markov chains demonstrated that organ dysfunction; for example, the timely administration of effective antibiotics and the prevention, early identification, 25% of observations of diabetic retinopathy will change from grade 1 to grade 5 or 6 in 17 years and that 25% will change or management of complications could be important variables in comparisons of care between different institutions after from grade 2 to grade 5 or 6 in 16 years [16] . For patients infected with HIV, the Markov model helped to estimate the controlling for case-mix differences. Furthermore, cost analysis may be refined if certain stages were found to be more interval (4.1 years) between seroconversion and a CD4 cell count persistently õ500/mm 3 but ú349/mm 3 [10]. The interval expensive than others. The examples cited are not intended to oversimplify the effect of a single therapy on the outcome between HIV seroconversion and a CD4 cell count of õ200/mm 3 was estimated at 8 years. of sepsis, but the ability to calculate the single effect of each of the interventions will help with the decision-making Previously, the term sepsis syndrome was somewhat confusing, and new definitions were proposed on the basis of the process of specific interventions. In the last 5 years, a number of immunotherapies for sepsis hypothesis of a hierarchical continuum. In a prospective, observational study [6] , we developed data supporting the hypothehave been tested in clinical trials [17 -25] . In general, the clinical trials have been conducted without a clear understanding sis. Among patients with SIRS, 26% (649 of 2,527) developed sepsis, 18% developed severe sepsis, and 4% developed septic of the natural history of sepsis. Furthermore, there were no models by which to predict the potential history of SIRS [6] . shock. However, the recently described stages of SIRS did not provide information on the probability of advancing or Herein, we illustrate with Markov modeling the natural history of the syndrome of sepsis and the potential benefits of effective regressing from one stage to the other. These calculations may be important for predicting the individual probabilities of deantisepsis therapies.
